Central Nervous System Progression in Advanced Non–small Cell Lung Cancer Patients With EGFR Mutations in Response to First-Line Treatment With Two EGFR-TKIs, Gefitinib and Erlotinib: A Comparative Study
BMC Cancer - United Kingdom
doi 10.1186/s12885-017-3165-0
Full Text
Open PDFAbstract
Available in full text
Date
April 4, 2017
Authors
Publisher
Springer Science and Business Media LLC